These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12464793)

  • 1. Understanding renal dose dopamine.
    Pierce JD; Morris DA; Clancy RL
    J Infus Nurs; 2002; 25(6):365-71. PubMed ID: 12464793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal-protective dose of dopamine: myth or reality?].
    de Werra P; Bracco D
    Rev Med Suisse Romande; 1999 Mar; 119(3):203-8. PubMed ID: 10218415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography.
    Katholi RE; Taylor GJ
    J Am Coll Cardiol; 2000 Jul; 36(1):306-7. PubMed ID: 10898454
    [No Abstract]   [Full Text] [Related]  

  • 4. What is "renal dose" dopamine?
    King JE
    Nursing; 2004 Sep; 34(9):26. PubMed ID: 15345933
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
    Triposkiadis FK; Butler J; Karayannis G; Starling RC; Filippatos G; Wolski K; Parissis J; Parisis C; Rovithis D; Koutrakis K; Skoularigis J; Antoniou CK; Chrysohoou C; Pitsavos C; Stefanadis C; Nastas J; Tsaknakis T; Mantziari L; Giannakoulas G; Karvounis H; Kalogeropoulos AP; Giamouzis G
    Int J Cardiol; 2014 Mar; 172(1):115-21. PubMed ID: 24485633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
    Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
    Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there still a role for low-dose dopamine use in acute heart failure?
    Torres-Courchoud I; Chen HH
    Curr Opin Crit Care; 2014 Oct; 20(5):467-71. PubMed ID: 25137402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose dopamine infusion in cirrhosis with refractory ascites.
    Lin SM; Lee CS; Kao PF
    Int J Clin Pract; 1998; 52(8):533-6. PubMed ID: 10622049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The case against renal dose dopamine in the pediatric intensive care unit.
    Rice BA; Tanski MC
    AACN Clin Issues; 2005; 16(2):246-51. PubMed ID: 15876891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of continuous furosemide and low-dose dopamine infusion in preeclampsia/eclampsia-related oliguria in the immediate postpartum period.
    Keiseb J; Moodley J; Connolly CA
    Hypertens Pregnancy; 2002; 21(3):225-34. PubMed ID: 12517329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and monitoring of haemodynamic complications in acute heart failure.
    Aspromonte N; Cruz DN; Valle R; Ronco C
    Heart Fail Rev; 2011 Nov; 16(6):575-81. PubMed ID: 21301959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low serum thyrotropin associated with intravenous dopamine infusion].
    Calvo Romero JM; Lima Rodríguez EM
    Med Clin (Barc); 2004 Jul; 123(5):199. PubMed ID: 15274802
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dopamine in "kidney-friendly" doses].
    Olsen NV; Bonde J
    Ugeskr Laeger; 2000 May; 162(20):2864-7. PubMed ID: 10860423
    [No Abstract]   [Full Text] [Related]  

  • 14. Eosinophilic myocarditis in patients awaiting heart transplantation.
    Takkenberg JJ; Czer LS; Fishbein MC; Luthringer DJ; Quartel AW; Mirocha J; Queral CA; Blanche C; Trento A
    Crit Care Med; 2004 Mar; 32(3):714-21. PubMed ID: 15090952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing i.v. therapy: "high-alert" drugs keep nurse managers ever watchful.
    Hadaway LC
    Nurs Manage; 2000 Oct; 31(10):38-40. PubMed ID: 15127556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose dopamine infusion reduces renal tubular injury following cardiopulmonary bypass surgery.
    Sumeray M; Robertson C; Lapsley M; Bomanji J; Norman AG; Woolfson RG
    J Nephrol; 2001; 14(5):397-402. PubMed ID: 11730274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose dopamine in critically ill oliguric patients: the influence of the renin-angiotensin system.
    Marik PE
    Heart Lung; 1993; 22(2):171-5. PubMed ID: 8449762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes.
    Valverde E; Pellicer A; Madero R; Elorza D; Quero J; Cabañas F
    Pediatrics; 2006 Jun; 117(6):e1213-22. PubMed ID: 16717120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.